Radiotherapy alone for T3~T4N0~N3 nasopharyngeal carcinoma
Liu Xiu-fan
Abstract
Liu Xiu-fan
Abstract
Objective To discuss the impact of different T and N stages for local-regional advanced nasopharyngeal carcinoma(NPC) on the clinical gains of radiotherapy(RT) alone. Methods From January to December in 1999, the data of 556 patients with 92' Fuzhou Staging System T3-4N0-3 in China were initially treated by conventional RT alone with the facio-cervical field were retrospectively reviewed. The total dose was 66-80Gy/6.5-8.0 weeks in the nasopharyngeal lesion, and 60-70Gy/6-7 weeks for the neck lymph nodes. Results The overall 5-year survival rate(OS) was 66.4%, with 69.1%,59.0% for T3,T4 lesions( P0.05). However, the difference between local control, disease-free survival, relapse-free survival or metastasis-free survival rate was not significant in T3,T4 lesions. The 5-year OS was 74.0%,66.0%,57.6% and 29.4% in N0,N1,N2 and N3 lesions, respectively(P0.01).The higher the N stage, the higher relapse and distant metastasis rate. Conclusions N stage is the dominant factor influencing the effect and prognosis of patients with local-regional advanced NPC treated by conventional RT alone. T stage was only the minor correlative factor. Using stratified combined radio-chemotherapy modality for different N stages of local-regional advanced NPC may act positively and effectively on resolving the cause of treatment failure--relapse and distant metastasis.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To discuss the impact of different T and N stages for local-regional advanced nasopharyngeal carcinoma(NPC) on the clinical gains of radiotherapy(RT) alone. Methods From January to December in 1999, the data of 556 patients with 92' Fuzhou Staging System T3-4N0-3 in China were initially treated by conventional RT alone with the facio-cervical field were retrospectively reviewed. The total dose was 66-80Gy/6.5-8.0 weeks in the nasopharyngeal lesion, and 60-70Gy/6-7 weeks for the neck lymph nodes. Results The overall 5-year survival rate(OS) was 66.4%, with 69.1%,59.0% for T3,T4 lesions( P0.05). However, the difference between local control, disease-free survival, relapse-free survival or metastasis-free survival rate was not significant in T3,T4 lesions. The 5-year OS was 74.0%,66.0%,57.6% and 29.4% in N0,N1,N2 and N3 lesions, respectively(P0.01).The higher the N stage, the higher relapse and distant metastasis rate. Conclusions N stage is the dominant factor influencing the effect and prognosis of patients with local-regional advanced NPC treated by conventional RT alone. T stage was only the minor correlative factor. Using stratified combined radio-chemotherapy modality for different N stages of local-regional advanced NPC may act positively and effectively on resolving the cause of treatment failure--relapse and distant metastasis.
Key concepts: Nasopharyngeal carcinoma, Medicine, Radiation therapy, Stage (stratigraphy), Internal medicine, Oncology, Distant metastasis, Chemotherapy